Latest Insider Transactions at Concert Pharmaceuticals, Inc. (CNCE)
This section provides a real-time view of insider transactions for Concert Pharmaceuticals, Inc. (CNCE). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of CONCERT PHARMACEUTICALS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of CONCERT PHARMACEUTICALS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 14
2022
|
James V Cassella Chief Development Officer |
SELL
Open market or private sale
|
Direct |
3,762
-1.94%
|
$11,286
$3.09 P/Share
|
|
Feb 14
2022
|
Jeffrey A Munsie Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
3,762
-3.52%
|
$11,286
$3.09 P/Share
|
|
Feb 14
2022
|
Nancy Stuart Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
6,049
-2.08%
|
$18,147
$3.08 P/Share
|
|
Jan 28
2022
|
Marc A. Becker Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
81,600
+22.46%
|
-
|
|
Jan 28
2022
|
James V Cassella Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Direct |
110,500
+23.75%
|
-
|
|
Jan 28
2022
|
Jeffrey A Munsie Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
63,700
+37.33%
|
-
|
|
Jan 28
2022
|
Nancy Stuart Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
120,400
+16.86%
|
-
|
|
Jan 28
2022
|
Roger D Tung Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
208,900
+9.75%
|
-
|
|
Jan 06
2022
|
Roger D Tung Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,240
-1.16%
|
$27,720
$3.09 P/Share
|
|
Jan 05
2022
|
Marc A. Becker Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,894
-4.52%
|
$8,682
$3.2 P/Share
|
|
Jan 05
2022
|
James V Cassella Chief Development Officer |
SELL
Open market or private sale
|
Direct |
2,894
-3.37%
|
$8,682
$3.19 P/Share
|
|
Jan 05
2022
|
Jeffrey A Munsie Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
2,894
-6.27%
|
$8,682
$3.2 P/Share
|
|
Jan 05
2022
|
Nancy Stuart Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
2,894
-1.67%
|
$8,682
$3.19 P/Share
|
|
Dec 15
2021
|
Roger D Tung Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
7,500
-0.94%
|
-
|
|
Dec 14
2021
|
Roger D Tung Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
7,000
-0.87%
|
-
|
|
Dec 13
2021
|
Roger D Tung Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
6,700
-0.82%
|
$20,100
$3.62 P/Share
|
|
Dec 13
2021
|
Roger D Tung Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,700
+0.82%
|
$20,100
$3.5 P/Share
|
|
Aug 16
2021
|
Marc A. Becker Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
7,304
-10.23%
|
$21,912
$3.28 P/Share
|
|
Aug 16
2021
|
James V Cassella Chief Development Officer |
SELL
Open market or private sale
|
Direct |
8,086
-8.6%
|
$24,258
$3.28 P/Share
|
|
Jun 10
2021
|
Richard Aldrich Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,125
+1.48%
|
-
|
|
Jun 10
2021
|
Thomas G Auchincloss Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,125
+30.6%
|
-
|
|
Jun 10
2021
|
Ronald W Barrett Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,125
+50.0%
|
-
|
|
Jun 10
2021
|
Jesper Hoeiland Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,125
+50.0%
|
-
|
|
Jun 10
2021
|
Peter Barton Hutt Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,125
+28.14%
|
-
|
|
Jun 10
2021
|
Wilfred E Jaeger Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,125
+50.0%
|
-
|
|
Jun 10
2021
|
Christi Van Heek Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,125
+25.31%
|
-
|
|
Feb 17
2021
|
Roger D Tung Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
13,480
-1.64%
|
$94,360
$7.2 P/Share
|
|
Feb 16
2021
|
Marc A. Becker Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,763
-5.01%
|
$26,341
$7.32 P/Share
|
|
Feb 16
2021
|
James V Cassella Chief Development Officer |
SELL
Open market or private sale
|
Direct |
3,763
-3.85%
|
$26,341
$7.32 P/Share
|
|
Feb 16
2021
|
Jeffrey A Munsie Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
3,763
-7.54%
|
$26,341
$7.32 P/Share
|
|
Feb 16
2021
|
Nancy Stuart Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
6,049
-3.37%
|
$42,343
$7.32 P/Share
|
|
Jan 05
2021
|
Marc A. Becker Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,700
+22.41%
|
-
|
|
Jan 05
2021
|
James V Cassella Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,700
+18.15%
|
-
|
|
Jan 05
2021
|
Jeffrey A Munsie Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,700
+30.3%
|
-
|
|
Jan 05
2021
|
Nancy Stuart Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,700
+10.79%
|
-
|
|
Jan 05
2021
|
Roger D Tung Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
69,300
+7.77%
|
-
|
|
Jun 10
2019
|
Bvf Partners L P > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
386,289
-14.49%
|
$3,862,890
$10.7 P/Share
|
|
Dec 19
2017
|
Bvf Partners L P > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
1,282,856
-46.87%
|
$33,354,256
$26.65 P/Share
|
|
Oct 19
2017
|
Bvf Partners L P > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
331,916
+10.28%
|
$4,978,740
$15.84 P/Share
|